NCT06868420

Brief Summary

The goal of this randomized controlled clinical trial was to determine the efficacy of play therapy in reducing perioperative anxiety in pediatric patients aged 3 to 6 years undergoing inguinal hernia surgery. The main research question was: Was play therapy effective in reducing perioperative anxiety levels in pediatric patients undergoing inguinal hernia repair? Primary outcome measure: Anxiety level. Patients were randomized into two groups:

  1. 1.an intervention group, which received play therapy involving a transport cart and toys; and
  2. 2.a control group, which received anxiolytic medication and standard care.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 19, 2023

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 23, 2023

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 20, 2024

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

February 19, 2025

Completed
20 days until next milestone

First Posted

Study publicly available on registry

March 11, 2025

Completed
Last Updated

April 15, 2025

Status Verified

April 1, 2024

Enrollment Period

6 months

First QC Date

February 19, 2025

Last Update Submit

April 10, 2025

Conditions

Keywords

Pediatric SurgeryAnxiety AssessmentHerniorrhaphyPlay TherapyPerioperative Anxiety

Outcome Measures

Primary Outcomes (2)

  • Parental Assessment of Child Anxiety Levels

    The child's anxiety levels were assessed by their parent or legal guardian using the Visual Analog Anxiety Scale for Parents (VAS-P). Baseline anxiety was measured at the first contact with the anesthesiologist. The VAS-P is a 10 cm horizontal scale, where values greater than 5 cm indicate significant anxiety.

    Baseline (pre-intervention), 5 minutes after the intervention (post-intervention), and 1 hour after the intervention (final assessment).

  • Anesthesiologist Assessment of Child Anxiety Levels

    The child's anxiety levels were assessed by the anesthesiologist using the Modified Yale Preoperative Anxiety Scale-Short Form (mYPAS-SF). Baseline anxiety was recorded at the first contact with the anesthesiologist. The mYPAS-SF provides scores ranging from 22.9 to 100 points, with values greater than 30 indicating the presence of significant anxiety.

    Baseline (pre-intervention), 5 minutes after the intervention (post-intervention), and 1 hour after the intervention (final assessment).

Study Arms (2)

CONTROL / STANDARD CARE

NO INTERVENTION

This group received standard care, including oral midazolam (0.1 mg/kg) as an anxiolytic before surgery.

Play Therapy With Transport Cart

EXPERIMENTAL

This group received a play-based intervention consisting of five minutes of play with a toy transport cart, after which the child was transported to the operating room using the same cart.

Behavioral: Play therapy with transport cart

Interventions

he intervention consisted of allowing pediatric patients to engage in five minutes of play with a toy transport cart, after which they were transported to the operating room in the same cart.

Play Therapy With Transport Cart

Eligibility Criteria

Age3 Years - 6 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Pediatric patients aged 3 to 6 years.
  • Patients of any sex.
  • Patients scheduled for elective inguinal hernioplasty.
  • Patients undergoing their first anesthetic-surgical procedure.
  • Patients whose legal guardian provided informed consent.

You may not qualify if:

  • Patients with known allergy to midazolam.
  • Patients with abnormal perinatal history (e.g., neonatal hypoxia or chromosomal abnormalities).
  • Patients undergoing emergency inguinal hernioplasty due to complications such as strangulation or incarceration.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Guadalajara

Guadalajara, Jalisco, 44280, Mexico

Location

MeSH Terms

Interventions

Play Therapy

Intervention Hierarchy (Ancestors)

Sensory Art TherapiesComplementary TherapiesTherapeuticsPsychotherapyBehavioral Disciplines and Activities

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD, Principal investigator

Study Record Dates

First Submitted

February 19, 2025

First Posted

March 11, 2025

Study Start

January 19, 2023

Primary Completion

July 23, 2023

Study Completion

March 20, 2024

Last Updated

April 15, 2025

Record last verified: 2024-04

Locations